Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
89Zr-bevacizumab PET imaging during everolimus treatment in neuroendocrine tumors
NL-OMON32849Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of everolimus in apudoma (NET), sponsored by University Medical Center Groningen. Primary endpoint: Change in 89Zr-bevacizumab uptake. Started Jul 2010; status: active, not recruiting.
02
Drugs
everolimus
03
Conditions
apudoma (NET)
Beyond the preview
Go deeper on NL-OMON32849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32849.